A Peculiar Paradox: How Stimulants Calm Down ADHD Brains

Scientists long theorized that the deficits seen in ADHD were due to alternate circuit wiring in the...

Attention Deficit & Hyperactivity Disorder, commonly known as ADHD, is a developmental disorder associated with difficulties in maintaining concentration, impulsive behaviors, and general inattentiveness (Mayo Clinic, 2019). 

Scientists long theorized that the deficits seen in ADHD were due to alternate circuit wiring in the frontal lobe, as this portion of the brain has long been linked with attention and executive functioning (Wilens & Spencer, 2010). In recent years, neuroimaging techniques have been employed to understand the structural and functional differences between ADHD brains and typically developing ones. These studies have shown decreased cortical thickness (essentially less dense patches of neurons) in several regions of the prefrontal cortex (including areas involved in attention and emotional processing), and areas of the temporal and parietal lobe, along with accompanied decreases in activation of these regions (Gehricke et al., 2017; Jadidian, Hurley, Taber, 2015; Wilens & Spencer, 2010). However, it is important to note that many of these differences normalize to some extent with age (Though adult ADHD can still persist regardless; Hoogman et al., 2019). 

On the level of neurotransmission, the working theory is that many of the intrinsic reward pathways in ADHD brains are chronically under-stimulated due to lower levels of free flowing dopamine and norepinephrine (Mehta et al., 2019). This under stimulation leads to reduced activity in the regions of the prefrontal cortex we previously spoke about. 

Traditional pharmacotherapies seek to treat ADHD through stimulants that increase the supply of dopamine and norepinephrine. There are two prominent types of stimulants: methylphenidates and amphetamines. Methylphenidates, like ritalin and concerta, work by blocking the reuptake of dopamine, allowing for dopamine to remain in the synapse between neurons for longer periods of time (causing more activation). Amphetamines, like adderall and vyvanse, both block reuptake and stimulate additional release of dopamine (Hodgkins et al., 2012; Seem & Madras, 1998).

With each passing day, scientists are working on more effective and less addictive treatments for ADHD. The future is bright, when it comes to helping those who are struggling!

Sources:

  • Attention-deficit/hyperactivity disorder (ADHD) in children - Symptoms and causes. (2019). Mayo Clinic; https://www.mayoclinic.org/diseases-conditions/adhd/symptoms-causes/syc-20350889
  • Attention-deficit/hyperactivity disorder (ADHD) in children - Symptoms and causes. (2019). Mayo Clinic; https://www.mayoclinic.org/diseases-conditions/adhd/symptoms-causes/syc-20350889Wilens, T. E., & Spencer, T. J. (2010). Understanding Attention-Deficit/Hyperactivity Disorder from Childhood to Adulthood. Postgraduate Medicine, 122(5), 97–109. https://doi.org/10.3810/pgm.2010.09.2206
  • Gehricke, Jean-G., Kruggel, F., Thampipop, T., Alejo, S. D., Tatos, E., Fallon, J., & Muftuler, L. T. (2017). The brain anatomy of attention-deficit/hyperactivity disorder in young adults – a magnetic resonance imaging study. PLOS ONE, 12(4), e0175433. https://doi.org/10.1371/journal.pone.0175433
  • Hoogman, M., Muetzel, R., Guimaraes, J. P., Shumskaya, E., Mennes, M., Zwiers, M. P., Jahanshad, N., Sudre, G., Earl, E. A., Soliva Vila, J. C., Khadka, S., Novotny, S. E., Hartman, C. A., Heslenfeld, D. J., Oranje, B., de Zeeuw, P., Chaim-Avancini, T. M., Rosa, P. G. ., Zanetti, M. V., … Seitz, J. (2019). Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples. The American Journal of Psychiatry, 176(7), 531–542. https://doi.org/10.1176/appi.ajp.2019.18091033
  • Jadidian, A., Hurley, R. A., & Taber, K. H. (2015). Neurobiology of Adult ADHD: Emerging Evidence for Network Dysfunctions. The Journal of Neuropsychiatry and Clinical Neurosciences, 27(3), 173–178. https://doi.org/10.1176/appi.neuropsych.15060142
  • Mehta, T. R., Monegro, A., Nene, Y., Fayyaz, M., & Bollu, P. C. (2019). Neurobiology of ADHD: A Review. Current Developmental Disorders Reports, 6(4), 235–240. https://doi.org/10.1007/s40474-019-00182-w
  • Seeman, P., & Madras, B. K. (1998). Anti-hyperactivity medication: methylphenidate and amphetamine. Molecular Psychiatry, 3(5), 386–396. https://doi.org/10.1038/sj.mp.4000421
  • Hodgkins, P., Shaw, M., Coghill, D., & Hechtman, L. (2012). Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options. European Child & Adolescent Psychiatry, 21(9), 477–492. https://doi.org/10.1007/s00787-012-0286-5


tags:
Codependency
Sleep
Relationships
Aging
Age
Bipolar
Creativity
Influence
Stress
Aging
Neuro Science
Religion
Ego
Body Positivity
Education
Cannabis
Therapy
Healing
Pharmaceutical
Anxiety
Meditation
Psychedelics
PTSD
Food
Eating Disorders
Women's Health
Women's Health
Pain
Mindfulness
Children
ADHD
Mental Disorder
Medicine
Sexuality
Gender
Family
Fitness
Neuro-Anatomy
Addiction
Depression
Mental Health
General Anxiety Disorder

Read more from

Jalen Rose

BROWSE ALL articles